MeSVA Department, Dental Unit, University of L'Aquila, P.Le S. Tommasi, 67100, L'Aquila, Italy.
Cova Samuele, DDS, Freelance, 38023, Cles, Trento, Via Tiberio Claudio, Italy.
BMC Oral Health. 2021 May 17;21(1):269. doi: 10.1186/s12903-021-01628-7.
This study aimed to verify the efficacy of two elastodontic devices in overjet (OJ) and overbite (OB) reduction during treatment with the Equilibrator Series II (Eptamed) and Occlus-o-Guide (Sweden & Martina) devices.
Sixty patients aged 7-15 years were enrolled in the study, and were divided into test and control groups. The test group included 30 patients (14 males, 16 females; mean age, 10.66 ± 2.12 years) treated with the EQ (Equilibrator) Series II. The control group included 30 patients (15 males, 15 females; mean age, 10.76 ± 2.52 years) treated with the Occlus-o-Guide. The two groups exhibited the same orthodontic features. The orthodontic criteria were: skeletal and dental class II malocclusion (divisions 1 and 2); and the presence of OJ and OB. Evaluation of OJ and OB was performed at two timepoints: T0 (before starting therapy) and T1 (after 1 year).
At T0, OJ and OB were similar for the two groups; however, at T1, both OJ and OB were significantly lower with the Eptamed device compared to the Occlus-o-Guide device (p = 0.0019).
Elastodontic devices improve orthodontic outcomes by aiding orthodontic patient management, diagnosis, and treatment planning, reducing the risk relapse acting on the whole organism and the rehabilitation of the tongue.
本研究旨在验证 Equilibrator Series II(Eptamed)和 Occlus-o-Guide(瑞典和马蒂娜)两种弹性牙齿矫正装置在治疗中对上颌前突(OJ)和覆盖(OB)减少的疗效。
本研究纳入了 60 名 7-15 岁的患者,并将其分为实验组和对照组。实验组包括 30 名患者(14 名男性,16 名女性;平均年龄 10.66±2.12 岁),采用 EQ(Equilibrator)Series II 治疗。对照组包括 30 名患者(15 名男性,15 名女性;平均年龄 10.76±2.52 岁),采用 Occlus-o-Guide 治疗。两组具有相同的正畸特征。正畸标准为:骨骼和牙齿 II 类错颌(1 类和 2 类);存在 OJ 和 OB。在两个时间点(T0,治疗开始前和 T1,治疗 1 年后)评估 OJ 和 OB。
T0 时,两组的 OJ 和 OB 相似;然而,在 T1 时,与 Occlus-o-Guide 装置相比,Eptamed 装置的 OJ 和 OB 明显更低(p=0.0019)。
弹性牙齿矫正装置通过辅助正畸患者管理、诊断和治疗计划,降低整个机体的复发风险和对舌的康复,改善正畸效果。